SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis

被引:45
作者
Henderson, Alex [1 ]
Douglas, F. [1 ]
Perros, P. [1 ]
Morgan, C. [2 ]
Maher, E. R. [3 ]
机构
[1] Newcastle Upon Tyne Hosp, NHS Fdn Trust, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England
[2] Birmingham Womens NHS Fdn Trust, Reg Genet Dept, Mol Genet Lab, Birmingham NE1 3BZ, W Midlands, England
[3] Univ Birmingham, Canc Res UK Renal Mol Oncol Grp, Birmingham, W Midlands, England
关键词
Hereditary paragangliomatosis; Oncocytoma; Renal cancer; SDHB; CELL CARCINOMA; FAMILIAL PARAGANGLIOMA; MUTATIONS; GENE; VHL; PHEOCHROMOCYTOMAS;
D O I
10.1007/s10689-009-9234-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations in SDHB are one of the causes of hereditary paraganglioma syndrome. Germline mutations in SDHB predispose to the development of head and neck paragangliomas and phaeochromocytomas. Renal tumours are also increasingly being reported as component tumours in hereditary paragangliomatosis associated with mutations in SDHB. We present the first reported case of a family in whom an individual shown to carry a mutation in SDHB developed a renal oncocytoma. We review other reports of renal tumours associated with SDHB-associated hereditary paragangliomatosis and suggest that various histological subtypes of renal tumours are part of this condition. This observation indicates that SDHB-associated hereditary paragangliomatosis is unlike most tumour predisposition syndromes associated with the development of renal tumours which are usually associated with specific histological sub-types. The increasing recognition of the involvement of renal tumours in SDHB mutation carriers suggests that renal screening is likely to be valuable for these patients. SDHB mutations should also be considered in the context of genetic testing when renal tumours, regardless of histopathology, present in families with other tumours consistent hereditary paraganglioma syndrome.
引用
收藏
页码:257 / 260
页数:4
相关论文
共 16 条
[1]   A case of familial paraganglioma syndrome type 4 caused by a mutation in the SDHB gene [J].
Drucker, Aaron M. ;
Houlden, Robyn L. .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (12) :702-706
[2]  
HEIMDAL K, 2007, GERMLINE SDHB START
[3]   Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas [J].
Klein, Roger D. ;
Jin, Long ;
Rumilla, Kandelaria ;
Young, William F., Jr. ;
Lloyd, Ricardo V. .
DIAGNOSTIC MOLECULAR PATHOLOGY, 2008, 17 (02) :94-100
[4]  
Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO
[5]  
2-G
[6]   von Hippel-Lindau disease [J].
Maher, ER ;
Kaelin, WG .
MEDICINE, 1997, 76 (06) :381-391
[7]   HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron [J].
Mandriota, SJ ;
Turner, KJ ;
Davies, DR ;
Murray, PG ;
Morgan, NV ;
Sowter, HM ;
Wykoff, CC ;
Maher, ER ;
Harris, AL ;
Ratcliffe, PJ ;
Maxwell, PH .
CANCER CELL, 2002, 1 (05) :459-468
[8]   The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis [J].
Maxwell, PH ;
Wiesener, MS ;
Chang, GW ;
Clifford, SC ;
Vaux, EC ;
Cockman, ME ;
Wykoff, CC ;
Pugh, CW ;
Maher, ER ;
Ratcliffe, PJ .
NATURE, 1999, 399 (6733) :271-275
[9]  
Neumann HPH, 2004, JAMA-J AM MED ASSOC, V292, P943, DOI 10.1001/jama.292.8.943
[10]   Searching for the hereditary causes of renal-cell carcinoma [J].
Pavlovich, CP ;
Schmidt, LS .
NATURE REVIEWS CANCER, 2004, 4 (05) :381-393